Phase I Cancer Trials: A Crucible of Competing Priorities
- 1 January 2001
- journal article
- review article
- Published by Wolters Kluwer Health in International Anesthesiology Clinics
- Vol. 39 (3) , 13-33
- https://doi.org/10.1097/00004311-200107000-00004
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Phase I trial design: Are new methodologies being put into practice?Annals of Oncology, 1996
- Statistical and Ethical Issues in the Design and Conduct of Phase I and II Clinical Trials of New Anticancer AgentsJNCI Journal of the National Cancer Institute, 1993
- Early Cancer Clinical Trials: Safety, Numbers, and ConsentJNCI Journal of the National Cancer Institute, 1993
- Using toxicity grades in the design and analysis of cancer phase i clinical trialsStatistics in Medicine, 1992
- Bayesian methods for phase I clinical trialsStatistics in Medicine, 1992
- Responses and toxic deaths in Phase I clinical trialsAnnals of Oncology, 1990
- EORTC guidelines for phase I trials with single agents in adultsEuropean Journal of Cancer and Clinical Oncology, 1985
- Design of Phase I and II Clinical Trials in Cancer: A Statistician's ViewCancer Investigation, 1984
- The therapeutic misconception: Informed consent in psychiatric researchInternational Journal of Law and Psychiatry, 1982
- Physician-Investigator/Patient-Subject: Exploring the Logic and the TensionJournal of Medicine and Philosophy, 1980